These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6103598)

  • 21. [Therapeutic management, the hospital environment].
    Gayral L
    Encephale; 1970; ():Suppl:19-25. PubMed ID: 5458709
    [No Abstract]   [Full Text] [Related]  

  • 22. Is the treatment of tobacco dependence with fluphenazine decanoate a causal treatment?
    Drtil J; Balasová G; Jandová E; Duchácková K
    Act Nerv Super (Praha); 1990 Dec; 32(4):301-2. PubMed ID: 2082649
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment of patients dependent on tobacco with fluphenazine decanoate.
    Drtil J
    Act Nerv Super (Praha); 1989 Jun; 31(2):116-7. PubMed ID: 2800941
    [No Abstract]   [Full Text] [Related]  

  • 24. [Advantages and indications of Moditen-Retard].
    Vallade L
    Encephale; 1970; ():Suppl:10-3. PubMed ID: 5458707
    [No Abstract]   [Full Text] [Related]  

  • 25. Plasma fluphenazine levels measured by high-performance liquid chromatography in patients treated with depot injections.
    Jouen F; Verité P; André D; Colonna L; Boucly P
    Arzneimittelforschung; 1993 May; 43(5):509-11. PubMed ID: 8328993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of age on the pharmacological management of ambulatory patients treated with depot neuroleptic medications for schizophrenia and related psychotic disorders.
    Mamo DC; Sweet RA; Chengappa KN; Reddy RR; Jeste DV
    Int J Geriatr Psychiatry; 2002 Nov; 17(11):1012-7. PubMed ID: 12404650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of schizophrenia. Long-term clinical studies with special reference to the combination of psychotherapy with depot neuroleptics.
    Lindberg D
    Acta Psychiatr Scand Suppl; 1981; 289():1-26. PubMed ID: 6110314
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical observation on the effect of domestic fluphenazine decanoate in the treatment of schizophrenia---report of 431 cases (author's transl)].
    Zhang YF
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1981 Aug; 14(3):182-5. PubMed ID: 7333179
    [No Abstract]   [Full Text] [Related]  

  • 29. Depot neuroleptics: the relevance of psychosocial factors--a United States perspective.
    Hogarty GE
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):36-42. PubMed ID: 6143746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of schizophrenic psychoses by sustained-action neuroleptics in psychiatric outpatients' treatment (author's transl)].
    Polácek J
    Cesk Psychiatr; 1982 Feb; 78(1):49-55. PubMed ID: 7060182
    [No Abstract]   [Full Text] [Related]  

  • 31. Experience with fluphenazine decanoate in the management of chronic schizophrenic outpatients.
    Gaby N; Lefkowitz D; Israel JR
    N C Med J; 1982 Sep; 43(9):641-4. PubMed ID: 6958987
    [No Abstract]   [Full Text] [Related]  

  • 32. [Implications of delayed-action drugs].
    Biéder J
    Ann Med Psychol (Paris); 1970 Oct; 2(3):424-7. PubMed ID: 5481457
    [No Abstract]   [Full Text] [Related]  

  • 33. [Flufenazine decanoate in the ambulatory treatment of schizophrenic patients].
    Populin M; De Vanna M; Poldrugo F
    Minerva Psichiatr; 1981; 22(2):85-92. PubMed ID: 7022095
    [No Abstract]   [Full Text] [Related]  

  • 34. Plasma fluphenazine levels by radioimmunoassay in schizophrenic patients treated with depot injections of fluphenazine decanoate.
    Wiles DH; Gelder MG
    Adv Biochem Psychopharmacol; 1980; 24():599-602. PubMed ID: 7405678
    [No Abstract]   [Full Text] [Related]  

  • 35. Diphenhydramine dependence: a need for awareness.
    de Nesnera AP
    J Clin Psychiatry; 1996 Mar; 57(3):136-7. PubMed ID: 8617701
    [No Abstract]   [Full Text] [Related]  

  • 36. [Depr;essive syndrome in the course of treatment with Mirenil prolongatum].
    Pawelkiewicz K; Sekrecki T
    Pol Tyg Lek; 1977 Oct; 32(44):1725-6. PubMed ID: 917920
    [No Abstract]   [Full Text] [Related]  

  • 37. Eleven years of experience with depot neuroleptics.
    Gross H; Kaltenbäck E; Pfolz H
    Acta Psychiatr Belg; 1981; 81(2):128-32. PubMed ID: 6117183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Is depot formulation a long-term optimal treatment option?].
    Musch A
    Med Monatsschr Pharm; 2005 Nov; 28(11):414-6. PubMed ID: 16309031
    [No Abstract]   [Full Text] [Related]  

  • 39. [Long-term treatment of outpatients with depot neuroleptics (author's transl)].
    Saameli W
    Schweiz Rundsch Med Prax; 1981 Feb; 70(6):206-10. PubMed ID: 6113584
    [No Abstract]   [Full Text] [Related]  

  • 40. [Psychological aspects of depot treatment of schizophrenic syndromes].
    Jacobsson L; Odling H
    Lakartidningen; 1980 Oct; 77(40):3522-6. PubMed ID: 6109045
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.